About this event
The last 15 years capillary electrophoresis (CE) has been widely used in the biopharmaceutical market for analyzing and characterizing biologics.
As the pharma industry moves into new therapeutic areas, driven amongst others by the COVID-19 pandemic, the need for fast and newly adapted analytical methods has evolved along.
Sciex has created new CE and CESI-MS workflows to help customers with their next generation biologics and vaccines analytics.
Dial into our one and a half hour webinar on June the 21st at 10AM to learn what solutions we are able to provide to support your analytical challenges.
Our speakers are Luc Van Laer from Analis and Steve Lock from Sciex. Both have long experience in the field of capillary electrophoresis and mass spectrometry.
Luc’s capillary electrophoresis talk will cover new workflows for gene therapy and vaccine analytics.
Steve will present the capabilities of capillary electrophoresis as an alternative front-end separation technique for mass spectrometry in the field of next generation biologics and vaccines analysis.
As a distributor and manufacturer of instruments and furniture for laboratories, ANALIS is a renowned company in the Benelux. Established in 1927, Analis is headquartered in Namur and has branch offices in Ghent and Rotterdam.
We are more than just your label of trust; we are YOUR QUALITY LABEL!